This third part of the Special Section on Melanoma and Melanocytic Proliferations concludes the series that started in the December 2010 issue of the Archives of Pathology & Laboratory Medicine. The goal was to include a very extensive review of clinical, morphologic, and molecular features of melanoma and related lesions. And we hope that the readership of the Archives will agree with us that the goal has now been achieved.Doina Ivan, MD, and Victor Prieto, MD, PhD, open the section with a description of histologic features recommended to be included in pathology reports involving melanoma. They discuss those features that probably should be included in all reports and the features that are recommended.Pedram Gerami, MD, and Artur Zembowicz, MD, PhD, review the current status of use of fluorescence in situ hybridization technique to help in the differential diagnosis of nevus and melanoma. This technique uses an algorithm including the results from a combination of 4 probes. The authors have first-hand knowledge in the application of such techniques to real cases and share their practical knowledge with the readership.In the third article, Jon Reed, MD, and Christopher Shea, MD, analyze the important topic of the distinction of melanoma in situ from other melanocytic proliferations in sun-damaged skin. This distinction becomes very important when dealing with small samplings of larger pigmented lesions.Equally interesting is the review of the topic of recurrent nevi. John Fox, MD; Jon Reed, MD; and Christopher Shea, MD, describe the morphologic features seen in melanocytic lesions that have suffered a trauma (including partial biopsies and accidental shaving). They emphasize the features that allow the distinction from melanoma as well as the use of immunoperoxidase as an adjunct in such differential diagnosis.With the demographic changes seen in our country, it is likely that the number of specimens from acral pigmented lesions (eg, acral nevi and acral melanocytic melanoma) will continue to rise. Therefore, the information provided by Francisco Bravo Puccio, MD, and Cesar Chian, MD, becomes very timely. Particularly important is their observation that clinicopathologic correlation is essential when dealing with these lesions, since small punches from a frank acral lentiginous melanoma may show minimal proliferation of benign-appearing melanocytes!Victor Prieto, MD, PhD, and Christopher Shea, MD, provide both a practical and comprehensive review of immunohistochemistry applied to the diagnosis of melanocytic lesions. They highlight the use of immunohistochemistry to detect melanocytic differentiation (eg, in the diagnosis of poorly differentiated lesions) and as an aid in the distinction between nevus and melanoma.Soheil Dadras, MD, PhD, completes the series with a review of what is known on molecular diagnostics in melanoma, that is, the current status and its perspectives.
Read full abstract